Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 4, 2004, Pages 1184-1193

  Taylor, Roger E ^a   Bailey, Clifford C ^b   Robinson, Kathryn J ^c   Weston, Claire L ^c   Ellison, David ^d   Ironside, James ^e   Lucraft, Helen ^d   Gilbertson, Richard ^f   Tait, Diana M ^g   Saran, Frank ^g   Walker, David A ^h   Pizer, Barry L ⁱ   Lashford, Linda S ^j  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

^h QUEEN S MEDICAL CENTRE   (United Kingdom)

ⁱ ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^j IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

more..

Author keywords

Medulloblastoma; Quality Assurance; Radiotherapy; Recurrence; Survival

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; TUMORS;

ETOPOSIDE; MEDULLABLASTOMA;

RADIOTHERAPY;

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MULTIVARIATE ANALYSIS; PREMEDICATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RANDOMIZATION; SKULL BASE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 12144289604     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.08.010     Document Type: Article

References (27)

1. Jenkin D., Goddard K., Armstrong D., et al. Posterior fossa medulloblastoma in childhood Treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys. 19:1990;265-274.
2. Bailey C.C., Gnekow A., Wellek S., et al. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO). Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma SIOP II. Med Pediatr Oncol. 2:1995;166-178.
3. Evans A.E., Jenkin R.D., Sposto R., et al. The treatment of medulloblastoma Results of a prospective randomised trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg. 72:1990;572-582.
4. Tait D.M., Thornton-Jones H., Bloom H.J., et al. Adjuvant chemotherapy for medulloblastoma The first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP). Eur J Cancer. 26:1990;464-469.
5. Deutsch M., Thomas P.R., Krischer J., et al. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. Pediatr Neurosurg. 24:1996;167-177.
6. Taylor R.E., Bailey C.C., Robinson K., et al. Results of a randomised study of pre-radiation chemotherapy vs radiotherapy alone for non-metastatic (M0-M1) medulloblastoma The SIOP/UKCCSG PNET-3 study. J Clin Oncol. 21:2003;1581-1591.
7. Taylor R.E., UKCCSG Radiotherapy and Brain Tumour Groups. Medulloblastoma/PNET and craniospinal radiotherapy (CSRT) Report of a workshop held in Leeds 30.6.99. Clin Oncol. 13:2001;58-64.
8. Carrie C., Alapetite C., Mere P., et al. French Medulloblastoma Group. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study The contribution of radiotherapy technique to tumour relapse. Radiother Oncol. 24:1992;77-81.
9. Carrie C., Hoffstetter S., Gomez F., et al. Impact of targeting deviations on outcome in medulloblastoma Study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys. 45:1999;435-439.
10. Chang C.H., Housepian E.M., Herbert C., et al. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology. 93:1969;1351-1359.
11. Kleihues P., Burger P.C., Scheithauer B.W. The new WHO classification of brain tumours. Brain Pathol. 3:1993;255-268.
12. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-482.
13. Parmar M.K.B., Machin D. Survival analysis a practical approach. 1995;J Wiley & Sons, Chichester, England.
14. Collett D. Modelling survival data in medical research. 1996;Chapman and Hall, London, England.
15. Zeltzer P.M., Boyett J.M., Finlay J.L., et al. Metastasis, stage, adjuvant treatment, and residual are prognostic factors for medulloblastoma in children Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 17:1999;832-845.
16. Kortmann R.-D., Kuhl J., Timmermann B., et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys. 46:2000;269-279.
17. Packer R.J., Goldwein J., Nicholson H.S., et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy A Children's Cancer Group study. J Clin Oncol. 17:1999;2127-2136.
18. Tarbell N.J., Friedman H., Kepner J., et al. Outcome for children with high stage medulloblastoma Results of the Pediatric Oncology Group 9031. [Abstract] Int J Radiat Oncol Biol Phys. 48:2000;179.
19. del-Charco J.O., Bolek T.W., McCollough W.M., et al. Medulloblastoma Time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys. 42:1998;147-154.
20. Hendry JH, Bentzen SM, Dale RG, et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol 1996;8:297-307.
21. Ito S., Hoshino T., Prados M.D., et al. Cell kinetics of medulloblastomas. Cancer. 70:1992;671-678.
22. Benk V., Bouhnik H., Raquin M.A., et al. Quality control of low dose craniospinal irradiation for low risk medulloblastoma. Br J Radiol. 68:1995;1009-1013.
23. Röttinger E.M., Bailey C.C., Bamberg M. Treatment of medulloblastoma-dependence of outcome on quality of radiotherapy. Radiother Oncol. 32:1994;S35.
24. Fukunaga-Johnson N., Lee J.H., Sandler H.M., et al. Patterns of failure following treatment for medulloblastoma Is it necessary to treat the entire posterior fossa? Int J Radiat Oncol Biol Phys. 42:1998;143-146.
25. Mah K., Danjoux C.E., Manship S., et al. Computed tomographic simulation of craniospinal fields in pediatric patients Improved treatment accuracy and patient comfort. Int J Radiat Oncol Biol Phys. 41:1998;997-1003.
26. Freeman C.R., Taylor R.E., Kortmann R.-D., et al. Radiotherapy for medulloblastoma in children An international perspective on current clinical research efforts. Med Pediatr Oncol. 39:2002;99-108.
27. Fukunaga-Johnson N., Sandler H.M., Marsh R., et al. The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma. Int J Radiat Oncol Biol Phys. 41:1998;77-82.